Featuring Award Winning Spatial Thermal Imaging©

ThermEval is honored to have been selected as a Top Radiology Solutions Provider, a distinction attributed to its ground-breaking contribution to medical imaging. Notably, ThermEval's Spatial Thermal Imaging (STI), a non-invasive technique that virtually strips away tissue enabling visualization of internal thermal sources, with resolution comparable to MRI.

STI reveals intricate anatomical information from conventional thermal images, exposing concealed details that otherwise would remain hidden.

Early Breast Cancer Detection

Spatial Thermal Imaging© non-invasively reveals anatomical details of breast tumors years before they are detectable with current screening methods, potentially enhancing breast cancer survival, reducing metastasis, and improving mortality.

Spatial Thermal Imaging (STI) is a non-invasive imaging procedure allowing visualization of the internal anatomical structure of the breast. STI detects the weak thermal signature accompanying even the youngest metabolic processes, and visualizes malignant breast cancer years before tumors are observable using invasive mammography, ultrasound or traditional breast thermography. STI is safe, affordable, and produces MRI-level resolution images with inexpensive equipment currently used by thousands of practices. STI combines the sensitivity of thermography with a proprietary software technique that provides anatomical visualization of blood vessels, cysts, and tumors, both benign and malignant. These visualizations overcome previous ambiguity and identify young, malignant that would likely remain hidden for years.

The power of STI is demonstrated in the following images of a breast hosting a three-tumor cluster (yellow arrow). Compared are mammography, traditional breast thermography, deep-tissue STI, and a close-up view of the tumors. The green arrow points to the smallest tumor, which is about 2mm in size.

Mammography
Breast Thermography
Deep-Tissue STI
STI Close-Up

Breast cancer survival has steadily improved, but mortality rate and the incidences of metastasized breast cancer have essentially remained unchanged for decades. Mammography, does not detect tumors early enough, and while breast thermography detects signs of cancer much earlier, the signs are ambiguous. If screening for earlier detection of breast cancer remains the best hope for reducing metastasis and improving mortality, a change is essential. STI answers the need by identifying tumors while in their infant stages.

STI embodies a deeper comprehension and knowledge. It's not only about seeing more; it's about knowing more and being empowered to act more effectively in the patient's interest. STI is an indispensable asset when the primary objective is to offer the highest level of care and service to patients.